Glaxosmithkline Pharmaceuticals slipped 7.76% to Rs 2,153 after the company reported 72.22% decline in consolidated net profit of Rs 45.72 crore in Q3 FY24 as against net profit of Rs 164.56 crore posted in Q3 FY23.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
